Cyclo Therapeutics, Inc. 8-K Report: Key Insights on Stock & Warrants (May 2023)

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

1. Entity Identification:

• Company Name: Cyclo Therapeutics, Inc.
• CIK: 0000922247
• SEC File Number: 000-25466
• IRS Employer Identification Number (EIN): 59-3029743
• Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
• Phone Number: 386-418-8060

2. Report Type:

• Form: 8-K (Current Report)

3. Reporting Date:

• Date of Report: May 2, 2023

4. Stock Information:

• Common Stock Ticker: CYTH
• Exchange: NASDAQ
• Warrants to Purchase Common Stock Ticker: CYTHW
• Exchange for Warrants: NASDAQ

5. Contextual Information:

• The report pertains to the common stock and warrants to purchase common stock, indicating that the financial details or disclosures might include aspects related to equity financing activities or changes in stock structure.

6. Period of Financial Reporting:

• Start Date: May 2, 2023
• End Date: May 2, 2023

Insights:

• Cyclo Therapeutics, Inc. is actively reporting on its equity instruments, specifically common stock and associated warrants, which may suggest recent or ongoing financing activities.
• The use of Form 8-K indicates that the company is disclosing significant events or corporate changes that investors should be aware of.
• The information regarding stock and warrants on NASDAQ suggests liquidity and market presence for the company's securities, which can be critical for investors and analysts following the stock.

Overall, this section provides essential context about Cyclo Therapeutics, Inc.'s current financial reporting status, significant financial instruments, and corporate identity, which are crucial for stakeholders assessing the company's performance and market position.